Externally-Led Patient Focused Drug Development (EL-PFDD) Meeting on Sarcoidosis patients and caregivers
Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA
31 oct. 2024 15h28 HE | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research (FSR) hosts Externally Led Patient-Focused Drug Development (EL-PFDD) meeting for Sarcoidosis
Tevogen Logo Notified.png
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
31 oct. 2024 10h54 HE | Tevogen Bio Inc
Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs. Tevogen’s AI...
Image press release Bioanalytical Expansion
Ardena Expands Bioanalytical Services in Europe
29 oct. 2024 07h24 HE | Ardena Holding NV.
Ardena expands bioanalytical services in the Netherlands with a new lab in Oss and enhanced capabilities in Assen to meet rising client demand.
Multiomics Market
Multiomics Markets Report 2024-2029: Major Players, Products, Platforms, Applications, Market Dynamics, and Geographic Opportunities
29 oct. 2024 06h48 HE | Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "Multiomics Market" report has been added to ResearchAndMarkets.com's offering. The global market for multiomics is expected to grow from $2.7...
22157.jpg
Optical Tweezers (Mechanobiology) Market Report 2024-2034 - Integration with Other Technologies like Raman Spectroscopy and Fluorescence Microscopy Presents Opportunities
28 oct. 2024 05h20 HE | Research and Markets
Dublin, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The "Optical Tweezers (Mechanobiology) Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Optical Tweezers...
Tevogen Logo Notified.png
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development
23 oct. 2024 08h35 HE | Tevogen Bio Inc
WARREN, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Modifi Bio logo 2022-07-25.png
Modifi Biosciences Acquired by Merck
23 oct. 2024 07h05 HE | Modifi Biosciences
NEW HAVEN, Conn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, today...
Biognosys_Logo_Color.png
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
17 oct. 2024 08h30 HE | Biognosys AG
Biognosys announced its participation in the 23rd Human Proteome Organization (HUPO) World Congress from October 20 to October 24 in Dresden, Germany.
Somerset, NJ, USA
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
14 oct. 2024 06h00 HE | Ardena Holding NV.
Ardena acquires Catalent's Somerset, NJ facility, expanding its US presence and boosting advanced oral drug product manufacturing capabilities.
Global Pharmacovigilance Market
Pharmacovigilance Industry Analysis Report 2024-2030: Biotechnology Companies Projected to Register the Most Lucrative CAGR (8%) due to Their Focus on R&D for Novel Products
10 oct. 2024 04h40 HE | Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmacovigilance Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The global...